Invitrogen Corporation
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 28, 2003

INVITROGEN CORPORATION


(Exact name of registrant as specified in its charter)
         
Delaware   0-25317   33-0373077

 
 
(State or other jurisdiction of
incorporation)
  (Commission File No.)   (IRS Employer Identification No.)
     
1600 Faraday Avenue, Carlsbad, CA   92008

 
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (760) 603-7200

Not Applicable


(Former name or former address, if changed since last report)

 


TABLE OF CONTENTS

Item 5. OTHER EVENTS
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

Item 5. OTHER EVENTS

     On July 28, 2003, Invitrogen Corporation (the “Company”) issued two press releases regarding its offering of $325 million aggregate principal amount of 2% Convertible Senior Notes due 2023 plus a 13 day over-allotment option to purchase up to an additional $48.25 million of 2% Convertible Senior Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Attached as Exhibits 99.1 and 99.2 are press releases of the Company regarding the offering of the Convertible Senior Notes. Exhibits 99.1 and 99.2 are incorporated by reference under this Item 5.

Item 7. FINANCIAL STATEMENTS AND EXHIBITS.

     (c)  Exhibits.

     
Exhibit   Description

 
99.1   Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes.
     
99.2   Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes.

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Invitrogen Corporation
         
Date: July 29, 2003   By:   /s/ C. Eric Winzer
C. Eric Winzer
Chief Financial Officer

 


Table of Contents

EXHIBIT INDEX

     
Exhibit   Description

 
99.1   Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes.
     
99.2   Invitrogen Corporation press release dated July 28, 2003 regarding the offering of convertible senior notes.